Surgical versus radiographic determination of para-aortic lymph node metastases before chemoradiation for locally advanced cervical carcinoma: A gynecologic oncology group study

Cancer

Volumn 112, Issue 9, 2008, Pages 1954-1963

  Gold, Michael A ^a   Tian, Chunqiao ^b   Whitney, Charles W ^c   Rose, Peter G ^d,e   Lanciano, Rachelle ^f   Mackey, Denise ^g  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c CHRISTIANA CARE HEALTH SYSTEM   (United States)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

^f Delaware County Memorial Hospital   (United States)

^g Four Penn Center   (United States)

Author keywords

Cervical cancer; Lymph node metastases; Surgical staging; Survival

Indexed keywords

CISPLATIN; FLUOROURACIL; HYDROXYUREA; DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18;

ADULT; ADVANCED CANCER; ARTICLE; BRACHYTHERAPY; CANCER GRADING; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTINUOUS INFUSION; FEMALE; HUMAN; INTERMETHOD COMPARISON; LYMPH NODE IRRADIATION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PARAAORTIC LYMPH NODE; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; TREATMENT INDICATION; TREATMENT OUTCOME; TUMOR VOLUME; UTERINE CERVIX CARCINOMA; AGED; COMPARATIVE STUDY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; RADIOGRAPHY; SURVIVAL RATE; UTERINE CERVIX TUMOR;

ADULT; AGED; COMBINED MODALITY THERAPY; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS;

EID: 42449086795     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23400     Document Type: Article

References (45)

1. Carl UM, Bahnsen J, Wiegel T. Radiation therapy of paraaortic lymph nodes in cancer of the uterine cervix. Acta Oncol. 1993;32:63-67.
2. Heller PB, Maletano JH, Bundy BN, Barnhill DR, Okagaki T. Clinical-pathologic study of stage IIB, III, and IVA carcinoma of the cervix: extended diagnostic evaluation for paraaortic node metastasis - a Gynecologic Oncology Group study. Gynecol Oncol. 1990;38:425-430.
3. Scheidler J, Hricak H, Yu KK, Subak L, Segal MR. Radiological evaluation of lymph node metastases in patients with cervical cancer, a meta-analysis. JAMA. 1997;278:1096-1101.
4. Chu KK, Chang SD, Chen FP, Soong YK. Laparoscopic surgical staging in cervical cancer - preliminary experience among Chinese. Gynecol Oncol. 1997;64:49-53.
5. Malur S, Krause N, Kohler C, Schneider A. Sentinel lymph node detection in patients with cervical cancer. Gynecol Oncol. 2001;80:254-257.
6. Chung HH, Lee S, Sim JS, et al. Pretreatment laparoscopic surgical staging in locally advanced cervical cancer: preliminary results in Korea. Gynecol Oncol. 2005;97:468-475.
7. Choi HJ, Roh JW, Seo SS, et al. Comparison of the accuracy of magnetic resonance imaging and positron emission tomography/computed tomography in the presurgical detection of lymph node metastases in patients with uterine cervical carcinoma. Cancer. 2006;106:914-922.
8. Odunsi KO, Lele S, Gamande S, Seago P, Driscoll DL. The impact of pre-therapy extraperitoneal surgical staging on the evaluation and treatment of patients with locally advanced cervical cancer. Eur J Gynecol Oncol. 2001:22;325-330.
9. Roh JW, Seo SS, Lee S, et al. Role of positron emission tomography in pretreatment lymph node staging of uterine cervical cancer: a prospective surgicopathologic correlation study. Eur J Cancer. 2005;41:2086-2092.
10. Rose PG, Adler LP, Rodriguez M, Faulhaber PF, Abdul-Karim FW, Miraldi F. Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: a surgicopathologic study. J Clin Oncol. 1999;17:41-45.
11. Narayan K, Hicks RJ, Jobling T, Bernshaw D, McKenzie AF. A comparison of MRI and PET scanning in surgically staged loco-regionally advanced cervical cancer: potential impact on treatment. Int J Gynecol Cancer. 2001;11:263-271.
12. Yeh LS, Hung YC, Shen YY, Kao CH, Lin CC, Lee CC. Detecting para-aortic lymph nodal metastasis by positron emission tomography of 18F-fluorodeoxyglucose in advanced cervical cancer with negative magnetic resonance imaging findings. Oncol Rep. 2002;9:1289-1292.
13. Lin WC, Hung YC, Yeh LS, Kao CH, Yen RF, Shen YY. Usefulness of F-fluorodeoxyglucose positron emission tomography to detect para-aortic lymph nodal metastasis in advanced cervical cancer with negative computed tomographic findings. Gynecol Oncol. 2003;89:73-76.
14. Gallup DG, King LA, Messing MJ, Talledo OE. Paraaortic lymph nodes sampling by means of an extraperitoneal approach with a supraumbilical transverse "sunrise" incision. Am J Obstet Gynecol. 1993;169:307-311.
15. Vasilev SA. A modified incision and technique for total retroperitoneal access and lymph node dissection. Gynecol Oncol. 1995;56:226-230.
16. Podczaski E, Stryker JA, Kaminski P, et al. Extended-field radiation therapy for carcinoma of the cervix. Cancer. 1990;66:251-258.
17. Rotman M, Pajak TF, Choi K, et al. Prophylactic extended-field irradiation of paraaortic lymph nodes in stages HB and bulky IB and IIA cervical carcinomas: ten-year treatment results of RTOG 79-20. JAMA. 1995;274:387-393.
18. Wharton JT, Jones HW III, Day TG Jr, Rutledge FN, Fletcher GH. Preirradiation celiotomy and extended field irradiation for invasive carcinoma of the cervix. Obstet Gynecol. 1977;49:333-338.
19. Fletcher GH. Lucy Wortham James Lecture: subclinical disease. Cancer. 1984;53:1274-1284.
20. Cosin JA, Potish RA, Adcock LL, Prem KA, Twiggs LB. Pretreatment surgical staging of patients with cervical carcinoma: the case for lymph node debulking. Cancer. 1998;82:2241-2248.
21. Marnitz S, Kohler C, Roth C, Fuller J, Hinkelbein W, Schneider A. Is there a benefit of pretreatment laparoscopic transperitoneal surgical staging in patients with advanced cervical cancer? Gynecol Oncol. 2005;99:536-544.
22. Kademian MT, Bosch A. Is staging laparotomy in cervical cancer justifiable? Int J Radiat Oncol Biol Phys. 1977;2:1235-1238.
23. Jolles CJ, et al. Complications of extended-field therapy for cervical carcinoma without prior surgery. Int J Radiat Oncol Biol Phys. 1986;12:179-183.
24. Kataoka M, Kawamura M, Nishiyama Y, et al. Patterns of failure and survival in locally advanced carcinoma of the uterine cervix treated with high dose-rate intracavitary irradiation system. Int J Radiat Oncol Biol Phys. 1991;22:31-35.
25. Kinney WK, Hodge DO, Egorshin EV, Ballard DJ, Podratz KC. Surgical treatment of patients with stages IB and IIA carcinoma of the cervix and palpably positive pelvic lymph nodes. Gynecol Oncol. 1995;57:145-149.
26. Whitney CW, Sause W Bundy BN, et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol. 1999;17:1339-1348.
27. Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med. 1999;340:1144-1153.
28. Lanciano R, Calkins A, Bundy BN, et al. Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a Gynecologic Oncology Group study. J Clin Oncol. 2005;23:8289-8295.
29. DiSaia PJ, Gall S, Levy D, Bundy B. Gynecologic cancer. In: Terry W, Rosenberg E, eds. Immunology of Human Cancer, vol 8. New York, NY: Elsevier/North Holland Biomedical Press; 1982:331-335.
30. Lagasse LD, Creasman WT, Shingleton HM, Ford JH, Blessing JA. Results and complications of operative staging in cervical cancer: experience of the Gynecologic Oncology Group. Gynecol Oncol. 1980;9:90-98.
31. Berman ML, Keys H, Creasman W, DiSaia P, Bundy B, Blessing J. Survival and patterns of recurrence in cervical cancer metastatic to periaortic lymph nodes (a Gynecologic Oncology Group study). Gynecol Oncol. 1984;19:8-16.
32. Petereit DG, Hartenbach EM, Thomas GM. Para-aortic lymph node evaluation in cervical cancer: the impact of staging upon treatment decisions and outcome. Int J Gynecol Cancer. 1998;8:353-364.
33. Vergote I, Amant F, Berteloot P, Van Gramberen M. Laparoscopic lower para-aortic staging lymphadenectomy in stage IB2, II, and III cervical cancer. Int J Gynecol Cancer. 2002;12:22-26.
34. Kim PY, Monk BJ, Chabra S, et al. Cervical cancer with paraaortic metastases: significance of residual paraaortic disease after surgical staging. Gynecol Oncol. 1998;69:243-247.
35. Stryker JA, Mortel R. Survival following extended field irradiation in carcinoma of cervix metastatic to para-aortic lymph nodes. Gynecol Oncol. 2000;79:399-405.
36. Vigliotti AP, Wen BC, Hussey DH, et al. Extended field irradiation for carcinoma of the uterine cervix with positive periaortic nodes. Int J Radiat Oncol Biol Phys. 1992;23:501-509.
37. Grigsby PW, Lu JD, Mutch DG, Kim RY, Eifel PJ. Twice-daily fractionation of external irradiation with brachytherapy and chemotherapy in carcinoma of the cervix with positive para-aortic lymph nodes: phase II study of the Radiation Therapy Oncology Group 92-10. Int J Radiat Oncol Biol Phys. 1998;41:817-822.
38. Varia MA, Bundy BN, Deppe G, et al. Cervical carcinoma metastatic to para-aortic nodes: extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy: a Gynecologic Oncology Group study. Int J Radiat Oncol Biol Phys. 1998;42:1015-1023.
39. Goff BA, Muntz HG, Paley PJ, Tamimi HK, Koh WJ, Greer BE. Impact of surgical staging in women with locally advanced cervical cancer. Gynecol Oncol. 1999;74:436-442.
40. Downey GO, Potish RA, Adcock LL, Prem KA, Twiggs LB. Pretreatment surgical staging in cervical carcinoma: therapeutic efficacy of pelvic lymph node resection. Am J Obstet Gynecol. 1989;160(5 pt 1):1055-1061.
41. Denschlag D, Gabriel B, Mueller-Lantzsch C, et al. Evaluation of patients with extraperitoneal lymph node dissection for cervical cancer. Gynecol Oncol. 2005;96:658-664.
42. Hasenburg A, Salama JK, Van TJ, Amosson C, Chiu JK, Kieback DG. Evaluation of patients after extraperitoneal lymph node dissection and subsequent radiotherapy for cervical cancer. Gynecol Oncol. 2002;84:321-326.
43. Holcomb K, Abulafia O, Matthews RP, Gabbur N, Lee YC, Buhl A. The impact of pretreatment staging laparotomy on survival in locally advanced cervical carcinoma. Eur J Gynaecol Oncol. 1999;20:90-93.
44. Lai CH, Huang KG, Hong JH, et al. Randomized trial of surgical staging (extraperitoneal or laparoscopic) versus clinical staging in locally advanced cervical cancer. Gynecol Oncol. 2003;89:160-167.
45. Havrilesky LJ, Kulasingam SL, Matchar DB, Myers ER. FDG-PET for management of cervical and ovarian cancer. Gynecol Oncol. 2005;97:183-191.